Methylprednisolone Market
                     Methylprednisolone 
Market
•(Infusion Type, Oral Type) and by 
Application (Medical, RandD): Global 
Opportunity Analysis and Industry 
Forecast, 2023-2032
Prime determinants of growth  
Download Sample Copy of Report
Methylprednisolone is a medication commonly known as Depo-Medol 
and Solu-Medol; it is a corticosteroid medication utilized to contain 
immune system responses that cause inflammation. It is used to treat 
various types of inflammatory conditions such as lupus, arthritis, 
psoriasis, ulcerative colitis, gland disorders, and different types of 
conditions affecting skin, lungs, stomach, and nervous system. The 
medication is given orally or into the vein or muscle.
Recent developments
in Methylprednisolone Market
►Increased Demand Due to COVID-
19 Treatment:Methylprednisolone, a ► Emerging Generics Market:The 
corticosteroid, gained attention as a 
market saw the entry of generic 
potential treatment for severe cases 
versions of methylprednisolone, 
of COVID-19. During the pandemic, 
which can offer cost-effective 
its demand surged in some regions 
alternatives to brand-name drugs.
due to its use in managing 
inflammation in COVID-19 patients.
KEY PLAYERS:
 Jubilant Transition  
Therapeutics,  Xianju Pharmacia
Cadista
Inc.
Teva 
Sandoz, Pfizer Endo 
Tianjin Kingyork Pharmaceuticals 
Inc International Plc
IntelGenx Corp
BY REGION:
•North America (U.S.,
•Canada, Mexico)
•Europe (France, Germany, Italy,
•Spain, UK, Rest of Europe)
•Asia-Pacific (China, Japan, India, 
South Korea, Australia, Rest of Asia-
Pacific)
•LAMEA (Brazil, South Africa, Saudi 
Arabia, Rest of LAMEA)
•David Correa 
•5933 NE Win Sivers Drive 
•#205, Portland, OR 97220 
•United States 
CONTACT •Toll-Free: 1-800-792-5285 •UK: +44-845-528-1300 
US: •Hong Kong: +852-301-84916 
•India (Pune): +91-20-66346060 
•Fax: +1-855-550-5975 
•[email protected] 
•Web: https://www.alliedmarketresearch.com 
•Follow Us on: LinkedIn Twitter
THANK 
YOU !